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ABSTRACT
Objectives To examine the association of 
sociodemographic characteristics with attendance at 
diabetic eye screening in a large ethnically diverse urban 
population.
Design Retrospective cohort study.
Setting Screening visits in the North East London Diabetic 
Eye Screening Programme (NELDESP).
Participants 84 449 people with diabetes aged 12 years 
or older registered in the NELDESP and scheduled for 
screening between 1 April 2017 and 31 March 2018.
Main outcome measure Attendance at diabetic eye 
screening appointments.
Results The mean age of people with diabetes was 60 years 
(SD 14.2 years), 53.4% were men, 41% South Asian, 29% 
White British and 17% Black; 83.4% attended screening. 
Black people with diabetes had similar levels of attendance 
compared with White British people. However, South Asian, 
Chinese and 'Any other Asian' background ethnicities showed 
greater odds of attendance compared with White British. 
When compared with their respective reference group, high 
levels of deprivation, younger age, longer duration of diabetes 
and worse visual acuity, were all associated with non- 
attendance. There was a higher likelihood of attendance per 
quintile improvement in deprivation (OR, 1.06; 95% CI, 1.03 
to 1.08), with increasing age (OR per decade, 1.17; 95% CI, 
1.15 to 1.19), with better visual acuity (OR per Bailey- Lovie 
chart line 1.12; 95% CI, 1.11 to 1.14) and with longer time 
of NELDESP registration (OR per year, 1.02; 95% CI, 1.01 to 
1.03).
Conclusion Ethnic differences in diabetic eye screening 
uptake, though small, are evident. Despite preconceptions, 
a higher likelihood of screening attendance was observed 
among Asian ethnic groups when compared with the White 
ethnic group. Poorer socioeconomic profile was associated 
with higher likelihood of non- attendance for screening. 
Further work is needed to understand how to target 
individuals at risk of non- attendance and reduce inequalities.
INTRODUCTION
Diabetic retinopathy is a common neurovas-
cular complication of diabetes and a major 
cause of blindness.1 2 There are at least 
3.9 million people diagnosed with diabetes 
in the UK, a number expected to rise to 
5.8 million by 2025.3 It is estimated that 30% 
of people with diabetes will develop reti-
nopathy, and about 9% will develop sight- 
threatening retinopathy.4 An early diagnosis 
through population screening, timely referral 
and treatment are essential for prevention 
of diabetes- related visual impairment.56 7 
The UK implemented the first systematically 
organised diabetic eye screening programme 
(DESP) in the world in England in 2003, 
achieving nationwide coverage by 2008. The 
English DESP offers annual mydriatic photo-
graphic screening to all people with diabetes 
aged 12 or older.5 In accordance with national 
standards, screening of ≥85% of the eligible 
diabetic population is considered achievable, 
however, English DESP uptake data from 
2016 to 2017 showed that this was not met 
in 75% of London’s Clinical Commissioning 
Groups (CCGs) areas.8 9 Regional differences 
Strengths and limitations of this study
 ► Strengths are that it is the largest population- based 
study in which the effect of sociodemographic fac-
tors on attendance at diabetic eye screening has 
been examined.
 ► A large urban multi- ethnic population with a broad 
range in its indices of deprivation was studied, mak-
ing the findings widely applicable.
 ► Data completeness was high in the population.
 ► A range of additional socioeconomic factors, in-
cluding the distance to screening centre and public 
transport accessibility level, were analysed.
 ► Systemic risk factors for diabetic retinopathy inci-
dence and progression, and the association of so-
ciodemographic variables with diabetic retinopathy 
were not available to analyse.
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in screening delivery and uptake may explain regional 
variation in diabetic eye disease.4
Non- attendance at annual diabetic eye screening 
visits has been associated with late presentation of sight- 
threatening retinopathy.7 10 Inequalities in health tend to 
be present in urban areas with contrasting sociodemo-
graphic conditions. London, a metropolis where people 
from the extremes of the deprivation indices live side- 
by- side, is a remarkable example of how these inequali-
ties can result in different uptake rates across and within 
boroughs.11–13 Health inequalities can create signifi-
cant attendance variation among subgroups, and are of 
concern to any screening programme. Sociodemographic 
factors such as, age,14–21 gender,21–23 ethnicity,14 15 23 trans-
portation24 and socioeconomic deprivation14–16 19–21 23 25 26 
have all been associated with non- attendance.
The North East London population is sociodemograph-
ically diverse, with a wide variation in ethnicities and a 
varied health profile with higher than average levels of 
deprivation and a lower than average life expectancy.27–29 
The North East London DESP (NELDESP) serves a total 
eligible population of approximately 125 000 people with 
diabetes aged 12 and over.27 The NELDESP aims to invite 
≥98% of eligible individuals and to have an uptake ≥85%. 
We have examined attendance at diabetic eye screening 
to identify which sociodemographic factors are determi-
nants of attendance in this large multi- ethnic population 
with high levels of deprivation.
METHODS
This was a 12- month retrospective cohort study of 
diabetic eye screening appointments occuring between 
1 April 2017 to 31 March 2018. Our outcome measure 
was attendance at diabetic eye screening. Potential deter-
minants of attendance include age, gender, self- defined 
ethnicity, area level deprivation, type of diabetes, dura-
tion of diabetes, visual acuity, years of NELDESP registra-
tion, distance to screening centre, and public transport 
accessibility.
Setting
The NELDESP is provided by the Homerton University 
Hospital NHS Foundation Trust. We analysed data from 
people with diabetes living in six CCG areas with inner 
city multi- ethnic populations. These are the London 
boroughs of Newham, Redbridge, Tower Hamlets and 
Waltham Forest, classified as the most ethnically diverse 
in London30 31; the borough of Hackney and the borough 
Barking and Dagenham, which both have a substantial 
multi- ethnic population.
The NELDESP is run according to English DESP guide-
lines. All people with diabetes aged 12 or older are iden-
tified through coding in primary care electronic record 
systems. Over the course of one year, every person eligible 
for Routine Digital Screening is offered multiple oppor-
tunities to attend. Eligibility for screening is defined by 
Public Health England.32 Software is used to generate 
invitations to attend for NELDESP appointments. The 
Homerton Hospital carries out appointment call/recall, 
screening, image grading, referral tasks, and is respon-
sible for providing clinical leadership and programme 
management, including failsafe procedures and internal 
quality assurance.27
Briefly, a screening visit entails a visual acuity assess-
ment, and pupil dilation to obtain two 45° digital retinal 
images of each eye, centred on the fovea and disc, respec-
tively. We have described in detail the imaging, grading 
protocol and referral pathway elsewhere.33
Any person attending any of the offered appointments 
over the course of one whole year was defined as ‘Attended’. 
Only those who failed to attend all appointments offered in 
the period were classified as ‘Did not attend’.
Data extraction
We carried out an anonymised data extraction of all 
screening appointments within the study period using 
structure query language (SQL) searches. An anony-
mised data base for analysis was created.
Independent variable recording
Ethnicity
Self- classified ethnicity data were collected from patients 
at the time of screening, or from the routinely recorded 
ethnicity data provided by their general practitioner 
(GP) surgery. Their ethnicity was recorded in the nation-
ally mandated screening software in accordance with the 
2011 Office for National Statistics census groups.30
Index of multiple deprivation
The English indices of deprivation are composed of 39 indi-
cators arranged in seven different domains of deprivation, 
which are combined and weighted to create the index of 
multiple deprivation (IMD), the official measure of rela-
tive deprivation in England. This measure is calculated 
for every neighbourhood or small area (lower- layer super 
output area (LSOA)) in England. There are 32 844 LSOAs 
with an average population of 1500, and each of them is 
ranked from 1st, the most deprived area, to 32, 844th, the 
least deprived area. Patients' postcodes were linked to their 
LSOA indices of multiple deprivation scores.
Visual acuity, distance and Public Transport Accessibility Level
We recorded the most recent visual acuity within a 3- year 
time frame in Snellen notation for the analysis. The 
better- seeing eye visual acuity score was assigned to each 
person. We calculated distance to screening centre (in 
kilometres) as a straight line from the patient’s postcode 
to the screening site. For patients who attended, the post-
code used was that known to the NELDESP on the day of 
attendance. For patients who failed to attend at any point 
within the study period, the postcode used was that known 
to the NELDESP on the date of the last offered appoint-
ment. The public transport accessibility level (PTAL) is 
a metric tool from Transport for London which rates 
locations by distance to the public transport network, 
thus reflecting the accessibility to public transport within 
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Greater London. The PTAL grade takes into account 
walk access time, average waiting time, service availability 
and service reliability. The grading has nine levels from 0 
(with the poorest access) to 6b (excellent access).34 Using 
Transport for London’s Web- based Connectivity Assess-
ment Toolkit (WebCAT),35 we extracted the PTALs for 
each patient’s home postcode.
Statistical analysis
We used R V.4.0.0 for statistical analysis.36 We conducted 
a multivariable logistic regression analysis of attendance 
at screening visit (binary outcome coded ‘1’ if patient 
attended and ‘0’ if they did not attend). A test for linear 
trend was performed if the ORs showed a linear pattern 
across categorical variables. Attendance was defined 
as a participant completing the diabetic retinopathy 
screening process. Independent variables considered 
were age, gender, ethnicity, IMD, type of diabetes, dura-
tion of diabetes, visual acuity, years of registration into the 
DESP, distance to screening centre and PTAL.
We categorised continuous variables for the analysis to 
allow for non- linear patterns in attendance. Rank scores 
of the IMD were split into quintiles following Office for 
National Statistics data of the English indices of depriva-
tion 2019, with the 1st quintile being the most deprived 
and the 5th quintile the least deprived areas.28 PTAL was 
divided into tertiles, with the 1st tertile having the worst 
PTAL (0, 1a, 1b) and 3rd tertile the best (5, 6a, 6b). 
Ethnicity was categorised as White British (White British, 
Irish, Any other White background), Mixed (White and 
Black Caribbean, White and Black African, White Asian, 
Any other Mixed background), Black (African, Carib-
bean, Any other Black background), South Asian (Indian, 
Pakistani, Bangladeshi), Chinese, Any other Asian back-
ground and Any other Ethnic group. Missing data points 
were categorised as ‘Unknown’ group within each inde-
pendent variable.
The reference category for ethnicity was the White 
British group, for IMD the most deprived quintile, and 
for PTAL the best tertile. For the rest of the independent 
variables, the group with the highest number of observa-
tions was considered the reference.
Patient and public involvement
Two patients provided insight into our discussion of the 
results of this study. We plan to disseminate the findings 
of our study to people eligible for diabetic eye screening 
and their families through the local press and via social 
media. In addition, we intend to seek wider dissemina-
tion to the public through the English national screening 
programme’s communication team.
RESULTS
A total of 84 449 people were invited for a screening 
appointment during the study period. Mean age was 
60 years (SD 14.2 years), 53.4% were men and 93.7% 
of those invited for screening had type 2 diabetes. The 
majority were of South Asian ethnicity (41.2%), followed 
by White British (29%) and Black ethnic groups (17%). 
74.7% of the participants lived in areas with the highest 
levels of deprivation (1st and 2nd IMD quintiles). Overall, 
screening attendance during the study period was 83.4%.
Table 1 summarises sociodemographic characteris-
tics of attenders and non- attenders along with crude 
and adjusted ORs for attendance versus non- attendance 
(where ORs greater than 1 imply greater odds of atten-
dance). In the text we refer to the adjusted OR from the 
multivariable linear regression model unless otherwise 
stated.
Those aged 12–45 years of age showed poorer atten-
dance when compared with the reference 46–60 year- old 
group. In adjusted analyses, participants 18–30 years of 
age were least likely to attend for screening showing a 
58% reduction in the odds of attendance, and an abso-
lute uptake difference of 18.8% when compared with the 
reference. Each decade rise in age increased the odds of 
attendance by about 17% (OR= 1.17; 95%CI 1.15-1.19, 
p- value < 0.001).
Compared with White British individuals, those of 
Mixed or Black ethnicity did not show any difference in 
the odds of attendance after adjustment. However, odds 
of attendance were higher among individuals of Asian 
(South Asian, Chinese and any other Asian background) 
ethnicities when compared with White British individ-
uals, even after adjustment.
Adjusted analyses showed that individuals living in the 
least deprived areas (5th IMD quintile) were most likely to 
attend for their screening appointments. Those in the 5th 
IMD quintile showed a 25% increase in the odds of atten-
dance compared with people living in the most deprived 
areas (1st IMD quintile). Each IMD quintile increase (i.e. 
less deprivation) suggested a 6% rise in the odds of atten-
dance (linear trend test p- value < 0.001).
People with longer duration of diabetes were less likely 
to attend. The OR per 5- year increase in duration of 
diabetes was 0.97 (95% CI 0.95 to 0.99, p value=0.019). 
The average distance to screening centre was 1.7 km (IQR 
1–2 km). Only people who lived ≥9 km from the screening 
centre (outside the geographical boundaries of the CCGs 
of North East London) were less likely to attend. Odds of 
attendance decreased by 1% for every km further from 
the screening centre; a non- signficant trend (OR=0.99; 
95% CI 0.97 to 1, p value=0.031).
Individuals with lower visual acuity (starting from 
visions worse than 6/9) showed a graded decline in the 
odds of attending the screening visit. Those with visual 
acuity worse than 6/18 were least likely to attend and 
showed a 60% reduction in odds of attendance compared 
with those with acuity of 6/6 to 6/9. This equates to an 
absolute difference in attendance of 11 percentage points 
when compared with the reference group.
Attendance did not appear to differ by gender, type 
of diabetes or PTAL score. People registered in the 
screening programme for more than 5 years were more 
likely to attend than those registered for less than 5 years. 
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Table 1 Sociodemographic characteristics of attenders and non- attenders along with crude and adjusted odds ratios (OR) for 
attendance versus non- attendance
Dependent: Attended* Attended n=70405 (83.4%)
Did not attend n=14044 
(16.6%)
Univariable OR (95% CI, 
p- value)
Multivariable adjusted OR† 
(95% CI, p- value)
Age
  12–17 years 276 (78.9) 74 (21.1) 0.73 (0.57–0.95, p=0.016) 0.71 (0.52–0.99, p=0.036)
  18–30 years†† 1003 (64.9) 543 (35.1) 0.36 (0.32–0.40, p<0.001) 0.42 (0.36–0.49, p<0.001)
  31–45 years 8296 (77.2) 2454 (22.8) 0.66 (0.62–0.70, p<0.001) 0.71 (0.66–0.76, p<0.001)
  46–60 years (Reference) 25 779 (83.7) 5029 (16.3) – –
  61–75 years 24 482 (86.4) 3856 (13.6) 1.24 (1.18–1.30, p<0.001) 1.28 (1.21–1.35, p<0.001)
  76–90 years 10 109 (84.0) 1930 (16.0) 1.02 (0.97–1.08, p=0.461) 1.20 (1.11–1.29, p<0.001)
  >90 years†† 460 (74.4) 158 (25.6) 0.57 (0.47–0.68, p<0.001) 0.92 (0.73–1.17, p=0.487)
  Per decade (Mean (SD)) 6.0 (1.4) 5.8 (1.6) 1.14 (1.13–1.15, p<0.001) 1.17 (1.15–1.19, p<0.001)
Gender
  Male (Reference) 37 569 (83.3) 7558 (16.7) – –
  Female 32 836 (83.5) 6486 (16.5) 1.02 (0.98–1.06, p=0.323) 0.99 (0.95–1.04, p=0.717)
Ethnicity
  White British (Reference) 20 040 (81.9) 4435 (18.1) – –
  Mixed 845 (77.7) 242 (22.3) 0.77 (0.67–0.90, p=0.001) 0.90 (0.75–1.09, p=0.264)
  Black 11 869 (82.9) 2454 (17.1) 1.07 (1.01–1.13, p=0.014) 1.02 (0.95–1.09, p=0.590)
  South Asian 29 708 (85.4) 5084 (14.6) 1.29 (1.24–1.35, p<0.001) 1.16 (1.09–1.23, p<0.001)
  Chinese 536 (89.8) 61 (10.2) 1.94 (1.50–2.56, p<0.001) 1.91 (1.39–2.71, p<0.001)
  Any other Asian background 4683 (88.0) 640 (12.0) 1.62 (1.48–1.77, p<0.001) 1.30 (1.17–1.45, p<0.001)
  Any other ethnic group 2248 (83.0) 460 (17.0) 1.08 (0.97–1.20, p=0.145) 1.05 (0.92–1.20, p=0.453)
  Unknown†† 476 (41.6) 668 (58.4) 0.16 (0.14–0.18, p<0.001) 0.32 (0.27–0.38, p<0.001)
IMD quintiles
  1st (most deprived, 
reference) 20 136 (81.9) 4456 (18.1) – –
  2nd 32 163 (83.5) 6359 (16.5) 1.12 (1.07–1.17, p<0.001) 1.09 (1.04–1.15, p=0.001)
  3rd 12 196 (84.7) 2203 (15.3) 1.23 (1.16–1.30, p<0.001) 1.17 (1.10–1.26, p<0.001)
  4th 4457 (85.1) 778 (14.9) 1.27 (1.17–1.38, p<0.001) 1.15 (1.04–1.27, p=0.009)
  5th (Least deprived) 1453 (85.4) 248 (14.6) 1.30 (1.13–1.49, p<0.001) 1.25 (1.06–1.50, p=0.012)
  Per quintile (Median (IQR)) 2 (1–4) 2 (1–3) 1.08 (1.05–1.10, p<0.001) 1.06 (1.03–1.08, p<0.001)
Type of diabetes
  Type 1 DM 2223 (75.8) 710 (24.2) 0.55 (0.51–0.60, p<0.001) 1.09 (0.96–1.25, p=0.190)
  Type 2 DM (Reference) 67 265 (85.0) 11 851 (15.0) – –
  MODY 40 (81.6) 9 (18.4) 0.78 (0.40–1.72, p=0.508) 0.85 (0.40–2.07, p=0.687)
  Not specified/other†† 877 (37.3) 1474 (62.7) 0.10 (0.10–0.11, p<0.001) 0.46 (0.40–0.53, p<0.001)
Duration of diabetes
  1–10 years (Reference) 44 890 (83.6) 8778 (16.4) – –
  11–20 years 20 327 (86.3) 3236 (13.7) 1.23 (1.18–1.28, p<0.001) 0.99 (0.92–1.06, p=0.727)
  >20 years 5057 (83.8) 977 (16.2) 1.01 (0.94–1.09, p=0.743) 0.87 (0.78–0.97, p=0.011)
  Unknown†† 131 (11.1) 1053 (88.9) 0.02 (0.02–0.03, p<0.001) 0.35 (0.26–0.47, p<0.001)
  Per 5 years(Mean (SD)) 1.9 (1.5) 1.7 (1.5) 1.05 (1.04–1.07, p<0.001) 0.97 (0.95–1.00, p=0.019)
Distance to centre
  ≤1–2 km (Reference) 55 436 (83.8) 10 752 (16.2) – –
  3–5 km 12 895 (82.4) 2758 (17.6) 0.91 (0.87–0.95, p<0.001) 0.97 (0.91–1.03, p=0.301)
  6–8 km 1044 (80.4) 254 (19.6) 0.80 (0.70–0.92, p=0.001) 0.90 (0.75–1.09, p=0.268)
  ≥9 km 190 (75.7) 61 (24.3) 0.60 (0.46–0.81, p=0.001) 0.66 (0.46–0.97, p=0.027)
  Unknown 840 (79.3) 219 (20.7) 0.74 (0.64–0.87, p<0.001) 0.93 (0.77–1.12, p=0.433)
  Per km(Mean (SD)) 1.7 (1.6) 1.8 (1.7) 0.97 (0.96–0.98, p<0.001) 0.99 (0.97–1.00, p=0.031)
Continued
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People with >15 years of registration showed almost twice 
the odds of attendance than people with <5 years of regis-
tration. The OR per 5 years of registration was 1.02 (95% 
CI 1.01 to 1.03, p value<0.001).
DISCUSSION
We found that people of Mixed or Black ethnicity with 
diabetes show very similar likelihoods of attendance at 
diabetic eye screening appointments compared with 
White British individuals. People of all asian ethnicities 
were more likely to attend than White British people in 
this large, well organised, sociodemographically diverse 
urban DESP. This is the most current study with large scale 
data on ethnicity and diabetic eye screening. In addition, 
those with poorer visual acuity, younger age and residing 
in areas with higher levels of deprivation were less likely 
to attend for diabetic eye screening appointments.
Principal findings and comparison with other studies
Black, Asian and minority ethnic (BAME) groups have 
been reported to be more likely to develop diabetic reti-
nopathy than White Europeans, more likely to present 
with sight- threatening retinopathy,15 37 38 and less likely 
to attend for diabetic eye screening.14 15 23 Attendance 
rates for BAME groups in our study were all higher than 
the White British, except for the small Mixed ethnic 
group, which had a lower, though non- significant, rate 
of attendance (4.2% uptake difference). Chinese, South 
Asian and any other Asian background ethnicities were 
most likely to attend, more so than any other ethnic group. 
These findings suggest that the underlying increased 
rates of retinopathy and sight- threatening retinopathy 
reported in BAME ethnic groups38 39 are not explained 
by non- attendance, raising the issue of increased suscep-
tibility or poorer diabetic control. A study by Gulliford et 
al.15 analysing sociodemographic inequalities in diabetic 
eye screening in South London also reported that African, 
Caribbean and other ethnicity groups were more likely to 
attend for diabetic eye screening than White Europeans. 
Of note is that there was a higher proportion of missing 
ethnicity data in their study when compared to ours 
(~39% vs 1.4%, respectively).
The commissioning and provision of diabetes eye 
screening programmes in England has improved since 
previous analyses were conducted, this may explain some 
of the difference between this and previous studies. The 
cultural and language barriers perceived to prevent older 
people from BAME groups attending in previous studies 
have proven to be misplaced. All appointment letters are 
written in English, these data show that the language of 
the letter was no barrier to better attendance. Indeed, 
uptake was higher among older people and those from 
BAME groups.
Dependent: Attended* Attended n=70405 (83.4%)
Did not attend n=14044 
(16.6%)
Univariable OR (95% CI, 
p- value)
Multivariable adjusted OR† 
(95% CI, p- value)
PTAL tertiles
  1st tertile 23 281 (83.2) 4714 (16.8) 0.95 (0.90–1.01, p=0.083) 0.95 (0.89–1.02, p=0.189)
  2nd tertile 36 535 (83.4) 7291 (16.6) 0.96 (0.91–1.02, p=0.192) 0.97 (0.90–1.03, p=0.309)
  3rd tertile (Reference) 10 589 (83.9) 2039 (16.1) – –
Visual acuity
  Better than 6/6 14 069 (88.7) 1798 (11.3) 0.93 (0.88–0.98, p=0.007) 1.08 (1.02–1.15, p=0.007)
  6/6 to 6/9 (Reference) 52 035 (89.4) 6158 (10.6) – –
  <6/9 to 6/18 3459 (84.7) 626 (15.3) 0.65 (0.60–0.72, p<0.001) 0.60 (0.55–0.66, p<0.001)
  Worse than 6/18†† 683 (78.4) 188 (21.6) 0.43 (0.37–0.51, p<0.001) 0.40 (0.34–0.48, p<0.001)
  Per five letters(Mean (SD)) 16.5 (1.6) 16.3 (2.0) 1.07 (1.06–1.08, p<0.001) 1.12 (1.11–1.14, p<0.001)
Years of registration
  1–5 years (Reference) 28 809 (80.9) 6822 (19.1) – –
  6–10 years 22 948 (84.8) 4103 (15.2) 1.32 (1.27–1.38, p<0.001) 1.13 (1.07–1.20, p<0.001)
  11–15 years 18 242 (85.6) 3072 (14.4) 1.41 (1.34–1.47, p<0.001) 1.22 (1.12–1.33, p<0.001)
  16–20 years 406 (89.6) 47 (10.4) 2.05 (1.53–2.81, p<0.001) 1.94 (1.35–2.89, p=0.001)
  Per year(Mean (SD)) 6.9 (3.9) 6.3 (3.9 1.04 (1.04–1.05, p<0.001) 1.02 (1.01–1.03, p<0.001)
Observations are for 84 449 individuals.
Bold p values indicate statistically significant results
Independent variables with missing data categorised as “Unknown”: type of diabetes (2.8%), duration of diabetes (1.4%), distance to screening centre (1.3%), and 
ethnicity (1.4%).
*ORs greater than one imply greater odds of attendance.
†ORs mutually adjusted for all factors shown in the table.
‡Variable groups with uptake below the national diabetic eye screening programme uptake goal of≥75%. Independent variables with missing data categorised as 
“Unknown”: type of diabetes (2.8%), duration of diabetes (1.4%), distance to screening centre (1.3%), and ethnicity (1.4%).
IMD, Index of Multiple Deprivation; MODY, Maturity onset diabetes of the young; PTAL, Public Transport Accessibility Level.
Table 1 Continued
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Socioeconomic deprivation has consistently been asso-
ciated with attendance, where those from more deprived 
areas are less likely to attend for eye screening appoint-
ments.14 16 19 20 25 26 Although the overall average differ-
ence in attendance of 3.5% between most and least 
deprived areas found in our study is less than the 9.3% 
reported in earlier studies,25 this is still greater than the 
2% uptake difference found in a population from South 
London in 2010.15 Our results provide further evidence of 
the ingrained health inequalities present in a multiethnic 
study population with high levels of deprivation. Also, 
we show the effect of multiple risk factors that appear 
to impact on attendance. Longer duration of diabetes 
and worsening visual acuity showed an association with 
non- attendance compared with individuals with shorter 
disease duration and better visual acuity. Previous reports 
have shown an association of longer duration of diabetes 
with non- attendance.15 16 Given that duration of diabetes 
is one of the three major risk factors for diabetic retinop-
athy,4 40 41 and considering that >60% of people with type 
2 diabetes and almost all people with type 1 diabetes will 
have diabetic retinopathy after 20+ years duration of the 
disease,40 the reduced odds of attendance observed in 
this group places them at increased risk of visual compli-
cations. There is, to our knowledge, no evidence available 
about the association of visual acuity with attendance to 
diabetic eye screening.
In other areas of the UK, increased distance from 
screening clinic has been associated with an increased 
risk of non- attendance.19 37 We have found that only 
individuals living ≥9 km from a screening centre were 
less likely to attend. It is noteworthy that an 8 km radius 
from one of the NELDESP screening centre covers all 
of the geographical areas of these six CCGs. People who 
are living more than 8 km from a screening centre have 
moved outside the CCG area and but remain registered 
with a North East London GP . Interestingly, we found 
that the association of distance to screening centre with 
non- attendance is independent from PTALs in this inner- 
city population. This may be due to London having 
a well- developed public transport network and good 
transport- related access. These findings may not apply 
elsewhere, particularly to non- urban populations less 
served by public transport.
In accordance with previous evidence,10 14–16 19 20 42 43 
young individuals from 12 to 45 years of age had lower 
odds of attendance compared with people aged 46–60 
years. Possible underpinning factors are over confidence 
about their health or demanding work schedules.19 24 
Nonetheless, within the context of diabetes chronicity 
and the need for regular contact with healthcare services, 
these individuals are at increased risk of complications 
through longer duration of disease and possible subop-
timal metabolic control.44
Our study has several strengths. First, a large sample 
size with considerable proportions of individuals from 
different ethnic groups representing a diverse popula-
tion group all living within the programme area, with one 
of the most complete data sets on ethnicity reported to 
date. Second, the use of PTALs in addition to distance 
to screening centre to evidence the associations of acces-
sibility and transport with attendance. And third, the 
fact that three- quarters of the participants were distrib-
uted between two of the most deprived quintiles of IMD, 
allowing the comparative association between depriva-
tion and ethnicity with attendance to be examined. Our 
study has several limitations. First, major systemic risk 
factors for diabetic retinopathy incidence and progres-
sion, namely hypertension and glycaemic control, were 
not available to include in our analysis. Second, we did 
not analyse the association of the sociodemographic vari-
ables with the presence of diabetic retinopathy, which 
although desirable, would have been difficult to ascertain 
for repeated non- attenders.
Further work to unravel the interplay between ethnicity, 
deprivation and disease severity, is needed to inform 
strategies to improve attendance, particularly in high risk 
under privileged groups.
CONCLUSION
Smaller previous studies have reported an association 
between non- White ethnicities and poor attendance at 
diabetic eye screening appointments. However, in this large 
diverse urban population, South Asian, Chinese and indi-
viduals of Any other Asian background were more likely to 
attend for diabetic eye screening than White British people. 
Public health strategies have in the past focused on ethnic 
differences as a possible cause of variance in diabetic eye 
screening uptake. The data from this large cohort shows that 
there are other more influential factors. We have shown that 
worse visual acuity, higher levels of deprivation, younger age 
and longer duration of diabetes are more predictive of non- 
attendance. Hence, strategies to improve uptake should be 
directed at these groups, in order to reduce inequalities in 
diabetic eye screening.
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